SlideShare a Scribd company logo
1 of 13
VSD
Case Presentation
By:
Mohammed Adel
1
Content
• Case overall view
• Problems list
• Labs & clinical findings
• Diagnosis
• Pharmacotherapeutic management
• Recommendations to be reported
2
Case overall view
A.Z. is a 4month old, 6Kgs male infant admitted with cough, fever and
difficulty of breath. Upon examination he is found cyanosed and dyspneic. The
symptoms started 2 wks ago and the parents were referred to the hospital by
external physician.
3
Problem list
• Fever
• Dyspnea
• Grunting
• Chest infection
• Cyanosis
• Mild jaundice
• Decreased feeding
4
Labs & clinical findings
• Na+ 141mmol/L
• K+ 5.06mmol/L
• SCr 0.6mg/dL
• Urea 32 mg/dL
• Alb. 3.9 g/dL
• PT 14.9 Sec
5
• PTT 46 Sec.
• INR 1.45
• ALT 18 IU/L
• AST 38 IU/L
• Bili. T. 0.6 mg/dL
• Hgb 10.7g/dL
• PLT 388×103/mm3
• WBC 10.6× 103/mm3
Labs & clinical findings
• Temp. 39°C
• BP 90/70 mmHg
• HR 140Bpm
• Tachypnea
• Pan systolic murmur
• Pneumonia patches on X-ray
• Large tender liver
6
Labs & clinical findings
• Echo revealed
• VSD 5.3 mm
• Dilated LV
• Severe TR
• PHTN 45 mmHg
7
Diagnosis
The patient suffers VSD complicated with acute episode of
heart failure and pneumonia
8
Pharmacotherapeutic management
• Cefepime 1gm diluted in 10 ml NS then
3ml IV q12hrs
• Amikin 500mg diluted in 5ml N.S then
administer IV 45” q12 hrs
• Lasix 4mg IV Q6hrs
• Calcium gluconate 6ml+ 10ml D5W
q8hrs
• Capoten® 6.25mg tablet1X3
• Vit.K injection as .5amp d Q24hrs
9
• Temporal syrup 2ml 1X4
• .5ml farcoline+ .5ml atrovent+ 2ml
N.S nebulizer Q4hrs
• 1 ml dopamine +7ml dobutamine on
100 ml NS <rate 7dps/min
• Lanoxin syrup 45” Q12hrs
• Potassium syrup 2ml q7hrs
Recommendations to be reported
Drug interactions:
Calcium salts decrease the effect of dobutamine
Good reliability
10
Recommendations to be reported
Precautions & Monitoring :
Captopril / furosemide
• Monitoring K level
Lanoxin /furosemide/ Ca gluconate
• ECG for arrhythmia
11
Recommendations to be reported
Pharmacotherapeutic intervention required:
Amikin dose should be switched to 30mg Q8hrs (5-7mg/kg/dose Q8hrs)
Lanoxin dose should be adjusted to 60mcg/day (10-15 Mcg/Kg)
Lasix dose sould be increased to 6mg/ dose intermittent IV doses
(1mg/Kg/dose)
Capoten dose should be decreased to 2mg Q8hrs (.3-.5mg/Kg/dose
Q8hrs)
Consider Hemoglobin correction
12
Thank You
13

More Related Content

What's hot

Paediatrics - Case presentation: fever+rash
Paediatrics - Case presentation: fever+rashPaediatrics - Case presentation: fever+rash
Paediatrics - Case presentation: fever+rash
patrickcouret
 
Acute pyelonephritis case
Acute pyelonephritis caseAcute pyelonephritis case
Acute pyelonephritis case
ronerahman
 

What's hot (20)

case presentation
case presentationcase presentation
case presentation
 
GBS case presentation
GBS case presentationGBS case presentation
GBS case presentation
 
Meningitis case presentation
Meningitis  case presentationMeningitis  case presentation
Meningitis case presentation
 
Paediatrics - Case presentation: fever+rash
Paediatrics - Case presentation: fever+rashPaediatrics - Case presentation: fever+rash
Paediatrics - Case presentation: fever+rash
 
Nephrotic Syndrome Case Presentation
Nephrotic Syndrome Case PresentationNephrotic Syndrome Case Presentation
Nephrotic Syndrome Case Presentation
 
Case presentation on STROKE
Case presentation on STROKECase presentation on STROKE
Case presentation on STROKE
 
A Case Presentation on Febrile Seizures
A Case Presentation on Febrile SeizuresA Case Presentation on Febrile Seizures
A Case Presentation on Febrile Seizures
 
Case Presentation - Is it alway GBS
Case Presentation - Is it alway GBSCase Presentation - Is it alway GBS
Case Presentation - Is it alway GBS
 
Stroke
StrokeStroke
Stroke
 
chronic liver disease
chronic liver diseasechronic liver disease
chronic liver disease
 
chronic kidney disease case presentation
chronic kidney disease case presentationchronic kidney disease case presentation
chronic kidney disease case presentation
 
COPD case presentation
COPD case presentation COPD case presentation
COPD case presentation
 
Case presentation on Cerebrovascular accident (Stroke)
Case presentation on Cerebrovascular accident (Stroke)Case presentation on Cerebrovascular accident (Stroke)
Case presentation on Cerebrovascular accident (Stroke)
 
Pediatrics Community Acquired Pneumonia case study.pptx
Pediatrics Community Acquired Pneumonia case study.pptxPediatrics Community Acquired Pneumonia case study.pptx
Pediatrics Community Acquired Pneumonia case study.pptx
 
Pediatric tuberculosis case presentation
Pediatric tuberculosis case presentationPediatric tuberculosis case presentation
Pediatric tuberculosis case presentation
 
An Interesting Case of Seizure
An Interesting Case of SeizureAn Interesting Case of Seizure
An Interesting Case of Seizure
 
Acute pyelonephritis case
Acute pyelonephritis caseAcute pyelonephritis case
Acute pyelonephritis case
 
Myocardial Infarction - Case Presentation and an Overview
Myocardial Infarction - Case Presentation and an OverviewMyocardial Infarction - Case Presentation and an Overview
Myocardial Infarction - Case Presentation and an Overview
 
Acute appendicitis -Case Presentation
Acute appendicitis -Case PresentationAcute appendicitis -Case Presentation
Acute appendicitis -Case Presentation
 
Clinical case discussion - myasthenia gravis
Clinical case discussion - myasthenia gravisClinical case discussion - myasthenia gravis
Clinical case discussion - myasthenia gravis
 

Viewers also liked

heart failure updated
heart failure updatedheart failure updated
heart failure updated
Mohammed Adel
 
IV drug preparation Open heart
IV drug preparation Open heartIV drug preparation Open heart
IV drug preparation Open heart
Mohammed Adel
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentation
Taher Haddad
 
Journal-Club-final-1
Journal-Club-final-1Journal-Club-final-1
Journal-Club-final-1
Mohammed Adel
 

Viewers also liked (20)

cover + presented
cover + presentedcover + presented
cover + presented
 
Antibiotics 1
Antibiotics 1Antibiotics 1
Antibiotics 1
 
Amitrityline overdose.pptx1
Amitrityline overdose.pptx1Amitrityline overdose.pptx1
Amitrityline overdose.pptx1
 
1contents
1contents1contents
1contents
 
cardio case (2)
cardio case (2)cardio case (2)
cardio case (2)
 
Cardiology morning presentation 2 im1962012
Cardiology morning presentation 2 im1962012Cardiology morning presentation 2 im1962012
Cardiology morning presentation 2 im1962012
 
heart failure updated
heart failure updatedheart failure updated
heart failure updated
 
colts foot
colts footcolts foot
colts foot
 
Anise as estrogenic agent
Anise as estrogenic agentAnise as estrogenic agent
Anise as estrogenic agent
 
Ventilator Management in Complex Congenital Heart Disease - a case-based review
Ventilator Management in Complex Congenital Heart Disease - a case-based reviewVentilator Management in Complex Congenital Heart Disease - a case-based review
Ventilator Management in Complex Congenital Heart Disease - a case-based review
 
Cardiology 1.4. Palpitations - by Dr. Farjad Ikram
Cardiology 1.4. Palpitations - by Dr. Farjad IkramCardiology 1.4. Palpitations - by Dr. Farjad Ikram
Cardiology 1.4. Palpitations - by Dr. Farjad Ikram
 
LVF with HTN and T2DM and PD
LVF with HTN and T2DM and PDLVF with HTN and T2DM and PD
LVF with HTN and T2DM and PD
 
Rheumatic fever
Rheumatic feverRheumatic fever
Rheumatic fever
 
IV drug preparation Open heart
IV drug preparation Open heartIV drug preparation Open heart
IV drug preparation Open heart
 
Ihab Suliman
Ihab SulimanIhab Suliman
Ihab Suliman
 
Angina pectoris presentation
Angina pectoris presentationAngina pectoris presentation
Angina pectoris presentation
 
Pi specialist, Roles & Responsibilities
Pi specialist, Roles & ResponsibilitiesPi specialist, Roles & Responsibilities
Pi specialist, Roles & Responsibilities
 
Project Heart Presentation(Students)
Project Heart Presentation(Students)Project Heart Presentation(Students)
Project Heart Presentation(Students)
 
Journal-Club-final-1
Journal-Club-final-1Journal-Club-final-1
Journal-Club-final-1
 
Cardiology 1.2. Dyspnea - by Dr. Farjad Ikram
Cardiology 1.2. Dyspnea - by Dr. Farjad IkramCardiology 1.2. Dyspnea - by Dr. Farjad Ikram
Cardiology 1.2. Dyspnea - by Dr. Farjad Ikram
 

Similar to pediatrics case VSD

Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
SMSRAZA
 
A case presentation of pediatric cystic hygroma
A case presentation of pediatric cystic hygromaA case presentation of pediatric cystic hygroma
A case presentation of pediatric cystic hygroma
razishahid
 
Clinical case discussion.pptx diabetic ketoacidosis
Clinical case discussion.pptx diabetic ketoacidosisClinical case discussion.pptx diabetic ketoacidosis
Clinical case discussion.pptx diabetic ketoacidosis
Viraj Shinde
 

Similar to pediatrics case VSD (20)

Daily round.pptx
Daily round.pptxDaily round.pptx
Daily round.pptx
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
Hypertensive crisis
Hypertensive crisisHypertensive crisis
Hypertensive crisis
 
A case presentation of pediatric cystic hygroma
A case presentation of pediatric cystic hygromaA case presentation of pediatric cystic hygroma
A case presentation of pediatric cystic hygroma
 
Clinical case discussion.pptx diabetic ketoacidosis
Clinical case discussion.pptx diabetic ketoacidosisClinical case discussion.pptx diabetic ketoacidosis
Clinical case discussion.pptx diabetic ketoacidosis
 
case presetation
case presetationcase presetation
case presetation
 
Post streptococcal gn by dr rashid
Post streptococcal gn by dr rashidPost streptococcal gn by dr rashid
Post streptococcal gn by dr rashid
 
Rickettsial disease
Rickettsial diseaseRickettsial disease
Rickettsial disease
 
Malaria PRESENTATION.pptx
Malaria PRESENTATION.pptxMalaria PRESENTATION.pptx
Malaria PRESENTATION.pptx
 
Hypoxic Ischemic Encephalopathy
Hypoxic Ischemic EncephalopathyHypoxic Ischemic Encephalopathy
Hypoxic Ischemic Encephalopathy
 
The unconscious patient and patient with altered consciousness- medical
The unconscious patient and patient with altered consciousness- medicalThe unconscious patient and patient with altered consciousness- medical
The unconscious patient and patient with altered consciousness- medical
 
Hypertensive encephalopathy
Hypertensive encephalopathyHypertensive encephalopathy
Hypertensive encephalopathy
 
Endocrine emergencies MCQ's/SBA
Endocrine emergencies MCQ's/SBAEndocrine emergencies MCQ's/SBA
Endocrine emergencies MCQ's/SBA
 
Critical case presentation1
Critical case presentation1Critical case presentation1
Critical case presentation1
 
Case presentation2
Case presentation2Case presentation2
Case presentation2
 
TB MENINGITIS CASE PRESENTATION
 TB MENINGITIS CASE PRESENTATION  TB MENINGITIS CASE PRESENTATION
TB MENINGITIS CASE PRESENTATION
 
CKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. GawadCKD MBD - Drug Related Issues - Dr. Gawad
CKD MBD - Drug Related Issues - Dr. Gawad
 
Conn’s syndrome
Conn’s syndromeConn’s syndrome
Conn’s syndrome
 
Conn’s syndrome
Conn’s syndromeConn’s syndrome
Conn’s syndrome
 
Hyperglycaemic Hyperosmolar State - Case Presentation
Hyperglycaemic Hyperosmolar State - Case PresentationHyperglycaemic Hyperosmolar State - Case Presentation
Hyperglycaemic Hyperosmolar State - Case Presentation
 

More from Mohammed Adel

UFH & LMWH & fondaparinux
UFH & LMWH & fondaparinuxUFH & LMWH & fondaparinux
UFH & LMWH & fondaparinux
Mohammed Adel
 
METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)
Mohammed Adel
 
Diabetic Keto-Acidosis final
Diabetic Keto-Acidosis finalDiabetic Keto-Acidosis final
Diabetic Keto-Acidosis final
Mohammed Adel
 

More from Mohammed Adel (6)

UFH & LMWH & fondaparinux
UFH & LMWH & fondaparinuxUFH & LMWH & fondaparinux
UFH & LMWH & fondaparinux
 
Bitter Melon
Bitter MelonBitter Melon
Bitter Melon
 
angina presentation
angina presentationangina presentation
angina presentation
 
streptogramin final
streptogramin finalstreptogramin final
streptogramin final
 
METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)METHOTRXATE (colored) 1 (1)
METHOTRXATE (colored) 1 (1)
 
Diabetic Keto-Acidosis final
Diabetic Keto-Acidosis finalDiabetic Keto-Acidosis final
Diabetic Keto-Acidosis final
 

pediatrics case VSD

  • 2. Content • Case overall view • Problems list • Labs & clinical findings • Diagnosis • Pharmacotherapeutic management • Recommendations to be reported 2
  • 3. Case overall view A.Z. is a 4month old, 6Kgs male infant admitted with cough, fever and difficulty of breath. Upon examination he is found cyanosed and dyspneic. The symptoms started 2 wks ago and the parents were referred to the hospital by external physician. 3
  • 4. Problem list • Fever • Dyspnea • Grunting • Chest infection • Cyanosis • Mild jaundice • Decreased feeding 4
  • 5. Labs & clinical findings • Na+ 141mmol/L • K+ 5.06mmol/L • SCr 0.6mg/dL • Urea 32 mg/dL • Alb. 3.9 g/dL • PT 14.9 Sec 5 • PTT 46 Sec. • INR 1.45 • ALT 18 IU/L • AST 38 IU/L • Bili. T. 0.6 mg/dL • Hgb 10.7g/dL • PLT 388×103/mm3 • WBC 10.6× 103/mm3
  • 6. Labs & clinical findings • Temp. 39°C • BP 90/70 mmHg • HR 140Bpm • Tachypnea • Pan systolic murmur • Pneumonia patches on X-ray • Large tender liver 6
  • 7. Labs & clinical findings • Echo revealed • VSD 5.3 mm • Dilated LV • Severe TR • PHTN 45 mmHg 7
  • 8. Diagnosis The patient suffers VSD complicated with acute episode of heart failure and pneumonia 8
  • 9. Pharmacotherapeutic management • Cefepime 1gm diluted in 10 ml NS then 3ml IV q12hrs • Amikin 500mg diluted in 5ml N.S then administer IV 45” q12 hrs • Lasix 4mg IV Q6hrs • Calcium gluconate 6ml+ 10ml D5W q8hrs • Capoten® 6.25mg tablet1X3 • Vit.K injection as .5amp d Q24hrs 9 • Temporal syrup 2ml 1X4 • .5ml farcoline+ .5ml atrovent+ 2ml N.S nebulizer Q4hrs • 1 ml dopamine +7ml dobutamine on 100 ml NS <rate 7dps/min • Lanoxin syrup 45” Q12hrs • Potassium syrup 2ml q7hrs
  • 10. Recommendations to be reported Drug interactions: Calcium salts decrease the effect of dobutamine Good reliability 10
  • 11. Recommendations to be reported Precautions & Monitoring : Captopril / furosemide • Monitoring K level Lanoxin /furosemide/ Ca gluconate • ECG for arrhythmia 11
  • 12. Recommendations to be reported Pharmacotherapeutic intervention required: Amikin dose should be switched to 30mg Q8hrs (5-7mg/kg/dose Q8hrs) Lanoxin dose should be adjusted to 60mcg/day (10-15 Mcg/Kg) Lasix dose sould be increased to 6mg/ dose intermittent IV doses (1mg/Kg/dose) Capoten dose should be decreased to 2mg Q8hrs (.3-.5mg/Kg/dose Q8hrs) Consider Hemoglobin correction 12